This is a low-signal insider cluster. The identical price ($8.20) and single-day concentration across multiple executives suggest a 10b5-1 plan or window-opening event rather than opportunistic selling. Lab-lead (CSO, CDO) participation also points to vesting-driven sales, not fundamental concern. Ignore for trading. Monitor the 30-day pipeline for any material clinical news that might have motivated the gift.
Price Chart
Executive Summary
Four OCUL insiders, including the Chief Scientific Officer and Chief Development Officer, conducted open-market sales of 28,999 shares for $238K, all at $8.20 on May 26, 2026. The cluster is small in magnitude (0.01% of the $1.9B market cap), concentrated on a single date, and likely driven by a shared trading-window opening or tax-planning event — not material negative information. The $0 gift of 394,696 shares by Dugel Pravin has no economic impact. Net direction is selling but routine for a mid-cap pharma company.
Key Financial Metrics
Key Facts
- Four C-suite/executive insiders sold 28,999 shares in open-market transactions on May 26, 2026, all at $8.20/share.
- Total cluster sales value: $237,792 — just 0.013% of OCUL's $1.9B market cap (well below the 0.1% triviality threshold).
- Dugel Pravin additionally gifted 394,696 shares on May 28 at $0 (non-economic event).
- No purchases occurred in the cluster window; the net direction is selling.
- The sales are small in dollar terms and cluster on a single date, consistent with a routine blackout-window opening or end-of-month 10b5-1 plan execution.
Financial Impact
Total insider sales of $238K represent 0.013% of market cap — economically trivial.
Risk Factors
- Historical performance on OCUL filing reports shows a 38% win rate and -6.91% average T+20 return — prior high-signal reads on this name have not been rewarded.
- A 394K-share gift by Dugel Pravin could precede share transfers to a trust or family member — no immediate price impact, but may reduce beneficial-owner alignment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-OCUL-1779999078058 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | Insider Cluster | $10.90 $7.67 | ▼ −29.63% | ▼ −29.30% | $6.96 (−36.15%) |
Aug 26, 2026 5w ago | Insider Cluster | $10.82 $9.82 | ▼ −9.24% | ▼ −8.73% | $6.96 (−35.67%) |
Aug 3, 2026 8w ago | 8-K | $8.40 $10.49 | ▲ +24.88% | ▲ +23.64% | $6.96 (−17.14%) |
Jun 17, 2026 15w ago | Press Release | $9.64 $9.17 | ▼ −4.93% | ▼ −6.24% | $6.96 (−27.80%) |
Jun 12, 2026 16w ago | 8-K | $8.99 $9.88 | ▲ +9.90% | ▲ +10.65% | $6.96 (−22.58%) |
Jun 4, 2026 17w ago | Press Release | $8.80 $9.64 | ▲ +9.55% | ▲ +10.92% | $6.96 (−20.91%) |
May 28, 2026 18w ago | Insider Cluster | $9.01 $9.90 | ▲ +9.88% | ▲ +11.67% | $6.96 (−22.75%) |
May 5, 2026 21w ago | 8-K | $9.71 $8.31 | ▼ −14.42% | ▼ −19.37% | $6.96 (−28.32%) |
May 5, 2026 21w ago | Press Release | $9.71 $8.31 | ▼ −14.42% | ▼ −19.37% | $6.96 (−28.32%) |
Apr 30, 2026 22w ago | DEFA14A | $9.43 $8.93 | ▼ −5.30% | ▼ −10.57% | $6.96 (−26.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access